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Loss of Fibrinogen Rescues Mice
from the Pleiotropic Effects
of Plasminogen Deficiency
Thomas H. Bugge,*† Keith W. Kombrinck,* Rifkin, 1988; Sappino et al., 1989; Sappino et al., 1991;
Rømer et al., 1994). Plg activation has also been associ-Matthew J. Flick,* Cynthia C. Daugherty,‡
ated with several pathological processes, most notablyMary Jo S. Danton,* and Jay L. Degen*
tumor cell invasion and atherosclerosis (Danø et al.,*Division of Developmental Biology
1985, 1994; Grainger et al., 1994).Children’s Hospital Research Foundation
Plasmin efficiently degrades fibrin and has a well-Cincinnati, Ohio, 45229
established role in fibrinolysis (Collen and Lijnen, 1994).†Finsen Laboratory
However, the biochemical function(s) of plasmin withinRigshospitalet
the context of general extracellular-matrix dissolution,DK-2100 Copenhagen Ø
tissue remodeling, and cell migration is less defined,Denmark
but different roles have been proposed. Plasmin has a‡Division of Pathology
relatively broad substrate specificity and is known toChildren’s Hospital Research Foundation
degrade several common extracellular-matrix glycopro-Cincinnati, Ohio, 45229
teins in vitro (Saksela and Rifkin, 1988; Vassalli et al.,
1991). In addition, Plg activation has been proposed to
lead to matrix degradation indirectly via activation ofSummary
the matrix metalloproteases (Werb et al., 1977). Further-
more, plasmin can activate several latent growth factorsPlasmin(ogen) is an extracellular serine protease im-
in vitro, including latent transforming growth factor b andplicated in the activation of latent growth factors and
latent basic fibroblast growth factor, and these activitiesprocollagenase, degradation of extracellular matrix
have been proposed to be of crucial importance for cellcomponents, and fibrin clearance. Plasminogen (Plg)
migration and tissue remodeling in vivo (Brunner et al.,deficiency in mice results in high mortality, wasting,
1991; Naldini et al., 1992; Odekon et al., 1994). Finally,spontaneous gastrointestinal ulceration, rectal pro-
a noncatalytic fragment of Plg, angiostatin, has recentlylapse, and severe thrombosis. Furthermore, Plg-defi-
been shown to be a potent inhibitor of angiogenesiscient mice display delayed wound healing following
(O’Reilly et al., 1994).skin injury, a defect partly related to impaired keratino-
The recent generation of mice with deficiencies in Plg,cyte migration. We generated mice deficient in Plg and
PA, uPA receptor (uPAR), and PA inhibitor-1 (Carmelietfibrinogen (Fib) and show that removal of fibrin(ogen)
et al., 1994a, 1994b; Bugge et al., 1995a, 1995b, 1996;from the extracellular environment alleviates the di-
Ploplis et al., 1995; Dewerchin et al., 1996) has provided
verse spontaneous pathologies previously associated
an extraordinary opportunity to define in greater detail
with Plg deficiency and corrects healing times. Mice
the role(s) of the Plg-activation system in vivo. Remark-deficient in Plg and Fib are phenotypically indistin-
ably, mice with each of these deficits, even in com-guishable from Fib-deficient mice. These data suggest
bination, were born normal in appearance, survived to
that the fundamental andpossibly only essential physi-
adulthood, and produced offspring. Thus, the major
ological role of Plg is fibrinolysis.
components of the PA-Plg system are not strictly re-
quired for development, growth, and reproduction. Nev-
ertheless, the consequences of either PA or Plg defi-
Introduction ciency are severe and include high mortality, wasting,
spontaneous ulcerations throughout the gastrointesti-
The proteolytic conversion of Plg to the active serine nal tract, widespread organ damage, rectal lesions,
protease plasmin is regulated by a complex system of spontaneous skin ulcerations (Carmeliet et al., 1994a;
proteins that includes urokinase-type Plg activator Bugge et al., 1995a; Ploplis et al., 1995), reduced ovula-
(uPA), tissue-type Plg activator (tPA), and Plg and PA- tion efficiency (Leonardson et al., 1995), impaired mam-
specific receptors and inhibitors (Danø et al., 1985; Sak- mary-gland involution (unpublished data), and suscepti-
sela and Rifkin, 1988; Vassalli et al., 1991; Collen and bility to bacterial infections (Gyetko et al., 1996).
Lijnen, 1994; Danø et al., 1994). Expression of compo- Moreover, when challenged by surgical skin injury, both
nents of the PA system, and thus the production of Plg- and PA-deficient mice took far longer to heal than
plasmin, is sensitive to a variety of growth factors, cyto- control animals and displayed a major impediment in
kines, and hormones, and appears to be intricately regu- keratinocyte migration over wound surfaces (Bugge et
lated in vivo during development and in adult life (Sak- al., 1996; Rømer et al., 1996). These later findings are
sela and Rifkin, 1988; Danø et al., 1985; Danø et al., particularly notable in that they clearly establish the im-
1994). Plg activation has been documented in a wide portance of PA/Plg in tissue remodeling and cell migra-
variety of physiological processes involving extracel- tion in vivo.
lular-matrix degradation, tissue remodeling and cell The critical issue of what constitutes the primary
migration, including ovulation, trophoblast invasion, em- mechanism(s) responsible for spontaneous-lesion for-
bryonic development, neuronal cell migration, inflamma- mation and delayed wound repair in PA/Plg-deficient
tion, angiogenesis, and wound healing (Strickland et al., mice could not be fully resolved in the initial studies of
1976; Bode and Dziadek 1979; Valinsky and Reich, 1981; these animals. The diverse spectrum of phenotypes
observed in the Plg-deficient animals could be viewedMarotti et al., 1982; Pepper et al., 1987; Moscatelli and
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Table 1. Hematological Parameters in Single and Double-Deficient Micea
Control Plg2/2 Fib2/2 Plg2/2/Fib2/2
White blood cells (3 109/liter) 4.2 6 0.7 5.3 6 4.0 4.2 6 1.3 3.8 6 1.3
Red blood cells (3 1012/liter) 9.2 6 1.2 8.6 6 0.6 8.3 6 0.4 8.5 6 0.4
Hemoglobin (g/%) 14.9 6 1.4 12.9 6 0.7 13.0 6 0.9 13.0 6 0.7
Hematocrit (%) 47.2 6 4.0 41.7 6 1.2 42.0 6 2.6 41.8 6 1.9
Mean corpuscular volume (fl) 51.5 6 2.2 48.7 6 1.9 50.3 6 1.7 49.2 6 1.2
Platelets (3 109/liter) 827 6 141 1263 6 996 769 6 209 881 6 267
a Data presented as mean 6 standard deviation of five control, three Plg2/2, five Fib2/2, and seven Plg2/2/Fib2/2 mice.
as compatible with functional deficits in virtually any sisting of 44 control mice, 25 Plg2/2 mice, 16 Fib2/2 mice,
and 23 Plg2/2/Fib2/2 mice. Plg2/2 mice had essentiallyof the processes previously associated with plasmin-
mediated proteolysis (e.g., growth-factor and protease normal weight gain until 2 months of age (Figure 1B).
Thereafter, a progressive weight loss was observed,activation, general matrix turnover, and fibrin clearance).
However, a consistent feature of the varied pathologies which became severe after 4 months. The weight of
Plg2/2 mice 6 months or older was uniformly less thanassociated with Plg or PA deficiency is vascular- and
extravascular-fibrin(ogen) deposits within affected or- two-thirds that of control mice (Figures 1A and 1B). In
contrast, mice lacking only Fib exhibited normal weightgans and tissues (Carmeliet et al., 1994a; Bugge et al.,
1995a; Ploplis et al., 1995; Rømer et al., 1996). To specifi- gain as adolescents and no wasting phenomenon as
adults, even when followed for more than 12 monthscally address the role of impaired fibrinolysis in the pleio-
tropic effects of Plg deficiency, we generated mice defi- (Figures 1A and 1B). Remarkably, in the same genetic
background, Plg2/2/Fib2/2 mice, despite their lifelongcient in both Plg and Fib. We report that Fib deficiency
rescues mice from the spontaneous pathologies known lack of Plg, exhibited the same excellent growth proper-
ties as those of control and Fib2/2 mice (Figures 1A andto befall Plg-deficient mice, suggesting that fibrinolysis
is the only essential physiological role of Plg. 1B). Indeed, no signs of weight loss or wasting were
observed in any of more than 20 Plg2/2/Fib2/2 mice that
were followed for more than a year. This dramatic rescue
from the severe-wasting syndrome normally associatedResults
with Plg deficiency provided a first indication that gen-
eral ill health in young Plg2/2 mice depended on fi-Generation of Mice with Combined Plg
and Fib Deficiency brin(ogen).
Interbreeding of previously described mouse lines car-
rying disrupted Plg (Bugge et al., 1995a) and Fib (Suh Fib Deficiency Reduces Morbidity and Increases
Life Expectancy of Plg-Deficient Miceet al., 1995) genes resulted in the generation of mice
with both single (Plg2/2, Fib2/2) and combined (Plg2/2/ Plg2/2 mice exhibited very high morbidity and mortality
(Figure 2 and Table 2). The median survival time of theFib2/2) deficiencies in Plg and Fib. Consistent with the
Mendelian inheritance pattern established previously for prospectively established cohort of Plg2/2 mice was 176
days, and all these Plg2/2 mice died or had to be euthan-the mutant Plg and Fib genes (Bugge et al., 1995a; Suh
et al., 1995), crosses between mice carrying both mutant ized by 301 days. Of the Plg2/2 mice, 40% died spontane-
ously. Apart from one mouse with a massive hemorrhagePlg and Fib alleles resulted in the birth of Plg2/2, Fib2/2,
and Plg2/2/Fib2/2 progeny in approximately the ratio ex- in the chest cavity, subsequent gross necroscopic anal-
ysis of Plg2/2 mice that had died spontaneously revealedpected, based on unlinked genes (data not shown). Mice
with each of these genotypes appeared normal at birth no obvious cause of death. The mice appeared to main-
tain an appetite until the time of death, as evidencedand generally survived to adulthood (see below). How-
ever, shortly after birth, a small fraction of neonates by the filled stomachs and intestines of all Plg2/2 mice
analyzed. Of the Plg2/2 mice, 52% developed spontane-displayed peritoneal bleeding from which they generally
recovered, a known feature of Fib-deficient mice (Suh ous rectal ulcerations, which over a period of a few
weeks progressed into frank rectal prolapse (Table 2).et al., 1995). Aside from the lack of clotting function and
fibrinolytic potential documented previously, we found Mice with ulcerating rectal prolapse had signs of serious
distress that necessitated euthanasia.no impact of the single or combined deficiencies on
the general hematological profile of the mice (Table 1). Although at risk for spontaneous catastrophic hemor-
rhaging, Fib2/2 mice generally exhibit good health in theSpecifically, nodifferences were found between animals
with regard to white blood cell, platelet, and red blood absence of overt challenges such as injury or pregnancy
(Suh et al., 1995). The penetrance of spontaneous fatalcell counts, hemoglobin, hematocrit, and mean cor-
puscular volume (Table 1). bleeding events depends highly on the genetic back-
ground of themice (Suh et al., 1995). In themixed genetic
background in this study (129/CF-1/Black Swiss), un-Fib Deficiency Alleviates Wasting
of Plg-Deficient Mice challenged Fib2/2 mice exhibited very modest pheno-
typic consequences, much like that described earlierTo examine the role of single and combined deficiencies
in overall growth and survival of the mice, we followed for Fib2/2 mice in an inbred C57Bl/6 genetic background
(Suh et al., 1995). The survival profile of the cohort ofthe fate of a prospective cohort of mice initially con-
Phenotypic Rescue of Plg-Deficient Mice
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A
Figure 2. Fib Deficiency Rescues Plg2/2 Mice from High Mortality
Survival data are shown for a prospective cohort of 44 control mice,
25 Plg2/2 mice, 16 Fib2/2 mice, and 23 Plg2/2/Fib2/2 mice that could
be followed for at least 320 days. See Table 2 for details on morbidity
and mortality of the mice.
Fib2/2 mice followed in this study was similar to that of
control mice (Figure 2 and Table 2). Of the 16 Fib2/2 mice
that could be followed for almost 1 year, only 2 (13%)
died, a fraction comparable with that in the cohort of
control mice followed in parallel (2 of 44 [5%] died within
the 320 day observation period). The excellent survivalB
characteristics of Fib2/2 mice made it possible to deter-
mine whether fibrin(ogen) deficiency was a benefit to
the general survival of Plg2/2 mice. The survival profile
of Plg2/2/Fib2/2 mice showed that a lack of fibrin(ogen)
rescued animals from the early morbidity and premature
death associated with Plg deficiency (Figure 2 and Table
2). The survival characteristics of Plg2/2/Fib2/2 mice were
comparable with those of Fib2/2 and control mice, with
only 2 (9%) of the cohort of 23 mice becoming terminally
ill within a 320 day observation period; 12 Plg2/2/Fib2/2
animals have been followed for more than 400 days
without any overt signs of disease. Parenthetically, it
should be noted that Fib2/2 and Plg2/2/Fib2/2 females
were also phenotypically similar (and distinct from Plg2/2
and control mice) with regard to their inability to survive
pregnancy beyond about 10 days (Suh et al., 1995 and
data not shown). Taken together, these data suggest
that the absence of fibrin(ogen) in Plg2/2 mice dramati-
cally increases survival but leaves the mice with the
same health and reproductive liabilities associated withFigure 1. Fib Deficiency Rescues Plg2/2 Mice from the Wasting Syn-
a total lack of clotting function (also see below). Thedrome
main threat to the health and life expectancy of Plg2/2/(A) Typical appearance of a control mouse, a Plg2/2 mouse, a Fib2/2
mouse, and a Plg2/2/Fib2/2 mouse at seven months of age. Note the Fib2/2 mice appears to be the risk of spontaneous or
severe wasting of the Plg2/2 mouse, whereas the appearance of the injury-induced hemorrhaging, an inherent feature of Fib
Plg2/2/Fib2/2 mouse is indistinguishable from the control and Fib2/2 deficiency.
mice.
(B) Plot of weight versus age of control mice (blue diamonds), Fib2/2
Pathology Associated with Plg Deficiencymice (red squares), Plg2/2 mice (green triangles), and Plg2/2/Fib2/2
Is Eliminated by Fib Deficiencymice (gold circles). The weights of a cohort initially consisting of 44
control mice, 25 Plg2/2 mice, 16 Fib2/2 mice, and 23 Plg2/2/Fib2/2 Detailed histological examination of tissues was per-
mice were measured at 1- to 2-week intervals. Bars indicate the formed on 13 Plg2/2 mice, including 8 young animals
standard deviation. Due to the high mortality associated with Plg (58–110 days old) and 4 older animals (175–211 days
deficiency, the number of Plg2/2 mice included in the weight mea- old). Of the 13 Plg2/2 mice examined, 5 were sacrificedsurements decreased over time as follows: days 20–100, 25 de-
due to rectal prolapse, 3 were apparently healthy youngcreasing to 19 mice; days 101–200, 19 decreasing to 8 mice; days
mice without signs of wasting, 4 were older mice with201–300, 8 decreasing to 1 mouse.
wasting, and 1 mouse was analyzed after dying sponta-
neously at 110 days (Table 3). All Plg2/2 mice analyzed
displayed a number of pathological features docu-
mented earlier in Plg2/2 mice with a 129-Black Swiss
Cell
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Table 2. Morbidity and Mortality of Single- and Double-Deficient Mice
No. Mice No. Mice Dying Within a Day of Death/
Group in Cohort 320-Day Observation Period Cause of Death/Euthanasia No. Mice Euthanasia (Median)
Control 44 2 (5%) Spontaneous death. 1 (2%) 266
No analysis.
Euthanized due to 1 (2%) 186
extensive skin ulceration.
Plg2/2 25 25 (100%) Euthanized due to an 13 (52%) 89–235 (165)
ulcerating rectal prolapse
with obvious distress to
animal.
Spontaneous death. Absent 10 (40%) 32–301 (190)
or inconclusive necropsy.
Massive hemorrhage of 1 (4%) 58
unidentified origin in chest
cavity.
Euthanized due to severe 1 (4%) 190
wasting.
Fib2/2 16 2 (13%) Spontaneous death. 2 (13%) 92, 286
No analysis.
Plg2/2/Fib2/2 23 2 (9%) Euthanized due to suspected 2 (9%) 61, 252
terminal hemorrhaging.a
a Appearance of animals indicated distress due to hemorrhaging. Gross examination of one mouse showed signs of an internal hemorrhage
of undetermined origin. The other mouse suffered resumed bleeding from the site of the tail biopsy.
genetic background (Bugge et al., 1995a). A uniform to that of the stomach ulcers (data not shown). Patholog-
ical changes were also frequently detected in the uro-feature of the Plg2/2 mice was multiple lesions scattered
throughout the liver, characterized by sinusoidal depos- genital and respiratory tracts. Pulmonary lesions with a
variable degree of cellular organization (Figure 3G) wereits of fibrillar material (Figure 3A). These fibrillar deposits
were shown to be rich in fibrin(ogen), based on immuno- detected in single sections of five of the mice; similar
lesions previously were shown to stain intensely usingstaining (data not shown; also see Bugge et al., 1995a).
The lesions displayed various degrees of organization a fibrin(ogen)-specific antibody (Bugge et al., 1995a).
Tracheal fibrin-rich lesions were found in single sectionswith infiltration of spindle cells, possibly macrophages,
and fibroblasts. Entrapment of necrotic hepatocytes from four Plg2/2 mice, in one case associated with necro-
sis (Table 3, and data not shown). Moreover, of sevenwithin the fibrillar material was a common feature in the
lesions. Anal-rectal ulceration was another prominent Plg2/2 virgin females examined, vaginal lesions were
documented in four (Table 3). A variety of other patholo-feature of Plg deficiency. Rectal ulceration was histolog-
ically documented in all five mice with rectal prolapse gies, possibly related to Plg deficiency, were also found
in individual Plg2/2 mice (Table 3, and data not shown).and in four of six mice without grossly apparent rectal
prolapse. The lesions were characterized by reactive Consistent with the remarkably strong growth and
survival characteristics of Plg2/2/Fib2/2 mice, none ofhyperplasia and surface exudate (Figure 3C).
The stomach, another part of the gastrointestinal the microscopic abnormalities specifically recognized in
Plg2/2 animals were documented in the 17 Plg-deficienttract, was highly prone to spontaneous ulceration in the
Plg2/2 mice (Table 3 and Figure 3E). One stomach ulcer mice that also lacked fibrin(ogen) (Figure 3 and Table
3). This group of Plg2/2/Fib2/2 mice included 14 44- toor more was observed in 10 of the 13 mice by inspection
of a single histological section from each mouse; the 3 110-day-old and 3 175- to 252-day-old mice that were
siblings of the histologically analyzed Plg2/2 mice. OfPlg2/2 mice without histologically detectable stomach
ulcers were among the youngest analyzed. The ulcers these Plg2/2/Fib2/2 mice, 15 were randomly selected,
apparently healthy animals, and 2 were preterminal ani-in the Plg2/2 mice had a characteristic morphology (Fig-
ure 3E), with a necrotic surface epithelium covered by mals sacrificed with suspected internal hemorrhaging
(see above). Pathology in the Plg2/2/Fib2/2 mice wasexudate, necrotic underlying tissue with diffuse distribu-
tion of fibrillar material, reactively altered hyperplasia of scarce and similar to that of nine Fib2/2 mice analyzed
in parallel (Table 3). The most prominent feature wasadjacent epithelium, and occasional vascular occlu-
sions in the lamina propria. Careful macroscopic exami- sporadic necrotic liver foci (single hepatocyte dropout),
a finding in 7 of the 17 Plg2/2/Fib2/2 mice and 3 of the 9nation of the stomachs of two older Plg2/2 mice revealed
multiple white foci compatible with the histologically Fib2/2 mice. The etiology of the single hepatocyte drop-
out was not evident, but Fib deficiency appears to con-detected ulcers (data not shown).
Histological inspection of single sections from other tribute, as similar lesions were not detected in the livers
of the 10 control mice analyzed in parallel (Table 3).parts of the gastrointestinal tract of the Plg2/2 mice re-
vealed colonic ulcers in three 110- to 169-day-old mice One Plg2/2/Fib2/2 mouse had an organizing subcapsular
hematoma typical of Fib2/2 mice (Suh et al., 1995). Otherand a duodenal ulcer in one 79-day-oldmouse. Morphol-
ogy of the colonic and duodenal ulcers was very similar pathologies in the two groups of mice that were not
Phenotypic Rescue of Plg-Deficient Mice
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Table 3. Histological Findings in Single- and Double-Deficient Mice
Age (Days) Frequen-
Group No. mice Median; Range Pathology cy a
Control 10 93; 37-186 Skin ulceration 1 (10%)
Plg2/2 13 110; 58-211 Liver lesions 13 (100%)
Rectal ulceration 10 (77%)
Glandular stomach ulcerb 9 (70%)
Vaginal lesionsc 4 (57%)
Pulmonary lesions 5 (39%)
Squamous stomach ulcer b 3 (23%)
Tracheal thrombi 3 (23%)
Colonic ulcer 3 (24%)
Cervicitisc, d 1 (14%)
Tracheal necrosis 1 (8%)
Larynx thrombi 1 (8%)
Kidney thrombi 1 (8%)
Esophageal ulcer 1 (8%)
Colitis 1 (8%)
Fib2/2 9 79; 37-109 Necrotic liver foci 3 (33%)
Pancreatic cyst 1 (11%)
Squamous stomach hemorrhage 1 (11%)
Plg2/2/Fib2/2 17 83; 44-252 Necrotic liver foci 7 (41%)
Hemorrhagic organized liver lesion 1 (6%)
Dystrophic calcification in liver 1 (6%)
Dystrophic calcification in duodenum 1 (6%)
a The data were collated from the analysis of one to two routine sections of organs from each mouse. The sections only cover a fraction of
any organ or tissue. The frequencies of the occurrence of the pathologies in the groups of mice are therefore likely to represent a significant
understatement.
b Macroscopic inspection of the stomach of two older Plg2/2 mice revealed 10–20 white foci, likely to be identical to the histologically detected
ulcers.
c Four control, two Fib2/2, seven Plg2/2, and six Plg2/2/Fib2/2 females were analyzed; all were virgins.
d Cervicitis was sporadically detected in the mouse colony and appears to be unrelated to the genotypes of the mice.
found in the control mice included hemorrhaging into with a dehydrated wound crust or scab the day after
surgery. In control mice, this scab was lost after aboutthe squamous part of the stomach of one Fib2/2mouse,
a pancreatic cyst in one Fib2/2 mouse, and dystrophic 10 days, revealing a thin residual defect. These mice
were scored as healed from days 11–13 after wounding,calcification in the liver and duodenum of individual
Plg2/2/Fib2/2 mice. Therefore, fibrin(ogen) deficiency res- based on the macroscopic closure of the incision inter-
face and restoration of epithelial covering (Figure 4B). Ascues Plg2/2 mice from the widespread tissue damage
specifically associated with lack of Plg, but Plg2/2/Fib2/2 expected from our earlier findings (Rømer et al., 1996),
wound healing in Plg2/2 mice was severely impaired (Fig-mice maintain many or all of the pathological features
of mice lacking Fib alone. ures 4A and 4B). The scab was retained longer, and
when lost, revealed a large, gaping wound field lacking
epidermal covering. This wound field eventually shrank,Rescue of Wound Healing in Plg-Deficient Mice
We have previously shown that healing of incisional skin and four of five wounds from thePlg2/2 mice weremacro-
scopically scored as healed from days 19–39 (Figurewounds is severely impaired in Plg2/2 mice (Rømer et
al., 1996). One major defect in Plg2/2 mice appears to 4B). In contrast, the progress of wound healing in Plg2/2/
Fib2/2 and Fib2/2 mice was similar to that observed inbe decreased keratinocyte migration from the wound
edges leading to delayed reepithelialization (Rømer et control mice (Figure 4 and see below). However, there
were slight macroscopic differences. For example, al-al., 1996). The fact that Fib2/2 mice can tolerate a full-
thickness skin incision without excessive bleeding (data though bleeding was modest in all groups following sur-
gery, the Plg2/2/Fib2/2 and Fib2/2 mice clearly differednot shown), and that healing time of skin wounds in
Fib2/2 mice is similar to that of control mice (Figure 4, and from control mice by the presence of distinctly larger
deposits of dried blood at the wound margins. In addi-data not shown), provided an opportunity to establish
whether a complex pathophysiological process, wound tion, the scabs of Plg2/2/Fib2/2 and Fib2/2 mice, presum-
ably consisting of dried blood and tissue exudate, ap-healing, was also corrected in Plg2/2 mice by the ab-
sence of fibrin(ogen). Incisional skin wounds were made peared initially less stable than in control animals, and
resumed bleeding was occasionally apparent in the firstin young Plg2/2/Fib2/2, Plg2/2, Fib2/2, and control mice,
and the appearance of the wounds and the progress in few days after surgery. When this scab was lost after
about 10 days, it revealed a thin residual defect similarthe healing processes were followed by macroscopic
inspection (Figures4A and 4B). The woundswere initially to that of the wounds in control mice. The wounds from
Plg2/2/Fib2/2 and Fib2/2 mice were scored as healed fromspindle-shaped with well-separated edges and covered
Cell
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Figure 3. Alleviation of Organ Pathology in
Plg2/2 Mice by Fib Deficiency
Representative histological sections of the
liver (A and B), rectum (C and D), glandular
stomach (E and F), and lung (G and H) of
Plg2/2 mice (A, C, E, and G) and Plg2/2/Fib2/2
mice (B, D, F, and H).
(A) Pathological changes in the liver of a 14-
week-old Plg2/2 mouse. Arrows indicate ne-
crotic hepatocytes trapped in fibrin-rich
patches.
(B) Section of a histologically normal liver
from a 16-week-old Plg2/2/Fib2/2 mouse. Ar-
rowheads delineate normal portal-tract struc-
tures. No necrotic hepatocytes are observed.
(C) Longitudinal section of the rectum of a 16-
week-old Plg2/2 mouse with rectal prolapse,
showing extensive ulceration of prolapsed
mucosa with surface exudate and reactive
hyperplasia (arrowheads). Triple arrows indi-
cate muscular layers prolapsed past the
squamocolumnar junction (asterisk).
(D) Longitudinal section of the rectum of a 13-
week-old Plg2/2/Fib2/2 mouse. The two sets of
double arrows indicate normal alignment of
anal structures at the squamocolumnar junc-
tion (asterisks).
(E) Ulceration of the glandular portion of the
stomach (arrows) of a 24-week-old Plg2/2
mouse.
(F) Section of histologically normal glandular
stomach and proximal duodenum of a
9-week-old Plg2/2/Fib2/2 mouse. The arrow-
head indicates the glandular stomach, the
arrow indicates Brunners glands underlying
the duodenum, and the asterisk indicates du-
odenal villi.
(G) Area of organization (arrows) in the lung
of a 17-week-old Plg2/2 mouse. The asterisks
indicate a bronchiole.
(H) Corresponding section of a histologically
normal lung of a 12-week-old Plg2/2/Fib2/2
mouse. The asterisk indicates a terminal
bronchiole. Magnification bars in A and B 5
35 mm; C and D 5 350 mm; E–H 5 100 mm.
days 11–15 and days 12–14, respectively (Figure 4B). sentative data in Figure 5), the keratinocyte outgrowths
extending from each wound edge had met and fusedThus, viewed macroscopically, the absence of Fib re-
stores the overall rate of wound healing in Plg2/2 mice to cover the wounds of control, Fib2/2, and Plg2/2/Fib2/2
mice completely, regardless of the section inspected.to normal.
To view the healing process microscopically, we col- In contrast, the fronts of migrating keratinocytes inPlg2/2
mice were located close to the wound margins in alllected wound tissues from three Plg2/2/Fib2/2, Plg2/2,
Fib2/2, and control mice at each of three time points sections examined, and the tips of keratinocyte wedges
often had a blunted appearance suggestive of a hin-after incision: days 3, 10, and 17. At day 3, the beginning
of an outgrowth of a wedge of keratinocytes could be drance in migration (see representative data in Figures
5C and 5D; also see Rømer et al., 1996). By day 17, theobserved at the margins of all wounds. At this time, no
major differences were found between the wounds in wounds from the control, Fib2/2, and Plg2/2/Fib2/2 mice
were well resolved with only a small residual scar atthe mice of different genotypes (data not shown). How-
ever, at days 10 and 17, dramatic differences were ob- the incision site (see representative data in Figure 5).
However, the wounds of Plg2/2 mice were sizable withserved. By days 10 (data not shown) and 17 (see repre-
Phenotypic Rescue of Plg-Deficient Mice
715
A Figure 4. Fib Deficiency Alleviates Impair-
ment of Incisional Skin-Wound Healing in
Plg2/2 Mice
(A) An example of progress in repair pro-
cesses in a control mouse, a Plg2/2 mouse, a
Fib2/2 mouse, and a Plg2/2/Fib2/2 mouse at
days 5, 12, and 16 after surgical incision. At
day 5, all wounds are of similar size. The Fib2/2
and Plg2/2/Fib2/2 wounds appear slightly
darker due to accumulation of dried blood at
the wound margins. At day 12, a small resid-
ual defect is present in the wound of the con-
trol, Fib2/2, and Plg2/2/Fib2/2 mice. In contrast,
the wound from the Plg2/2 mouse is still large;
the scab is lost, and the wound appears red
due to protruding granulation tissue. At day
16, the wounds of the control, Fib2/2, and
Plg2/2/Fib2/2 mice have healed, and new fur
has grown to cover the wounds. The wound
of the Plg2/2 mouse is covered by a hard,
scaly surface that lacks epidermal coverage.
(B) Plot of the percentage of mice healed ver-
sus time after surgical incision: control mice
(squares; n 5 6), Plg2/2 mice (triangles; n 5
5), Fib2/2 mice (circles; n 5 6), and Plg2/2/
Fib2/2 mice (diamonds; n 5 8).
pronounced lingering scabs (Figures 5C and 5D). De- evidence that fibrin(ogen) is essential to the expression
of all spontaneous pathologies previously establishedspite the obvious slow progress in wound repair in Plg2/2
mice, it should be noted that these mice and Plg2/2/ in Plg-deficient mice. Furthermore, our results show that
one defect revealed in experimentally challenged Plg2/2Fib2/2 and Fib2/2 mice uniformly showed many features
of normal repair, including formation of granulation tis- mice, delayed wound healing in the skin (Rømer et al.,
1996), is also effectively corrected by the absence ofsue and pronounced angiogenesis (Figure 5, and data
not shown). However, quantitative differences in these fibrin(ogen). The latter finding is particularly noteworthy
given that wound healing is extremely complex and in-processes cannot presently be excluded.
volves a combination of processes that have been pre-
viously tied to Plg activation, including inflammatoryDiscussion
response, cell proliferation and migration, angiogenesis,
and tissue remodeling (Clark and Henson, 1988; Don-Plg deficiency is compatible with development to term
and growth to sexual maturity; however, the pathologi- aldson and Mahan, 1988; also see the Introduction).
Taken together, these findings strongly suggest that thecal consequences of this deficit are severe, and the
prospects for long-term survival are bleak (Bugge et al., critical and possibly only essential physiological role of
the Plg-activation system is fibrinolysis.1995a; Plopliset al., 1995; this report). Plg-deficient mice
have a myriad of disorders, including progressive and Although tissue damage associated with vascular and
extravascular fibrin deposits constituted the dominantwidespread organ damage, wasting, and ultimately pre-
mature death. The studies presented here provide direct pathological theme in Plg2/2 mice (Bugge et al., 1995a;
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Figure 5. Restoration of Keratinocyte Migra-
tion in Plg2/2 Mice by Fib Deficiency
Hematoxylin- and eosin-stained histological
sections show a representative example of
progress in wound repair in a control mouse
(A and B), a Plg2/2 mouse (C and D), a Fib2/2
mouse (E and F), and a Plg2/2/Fib2/2 mouse
(G and H) 17 days after wounding. (A), (C),
(E), and (G) are low magnifications showing
the overall histological appearance of the
wounds. (B), (D), (F), and (H) are high magnifi-
cations of the same sections demonstrating
the progress in reepithelialization. By day 17,
the keratinocyte wedges in the wounds from
the control, Fib2/2, and Plg2/2/Fib2/2 mice have
met and fused to reepithelialize the wounds
completely (arrows). Furthermore, in mice of
each of these genotypes, granulation tissue
has matured to form a scar. In contrast, at
day 17, the wound from the Plg2/2 mouse is
still covered by a scab (asterisk in C and D),
and the keratinocyte wedges (leading edges
indicated by arrows) are near the wound mar-
gins. Magnification bars in (A), (C), (E), and
(G) 5 475 mm; (B), (D), (F), and (H) 5 200 mm.
Ploplis et al., 1995), a lingering question has been the is merely fibrinolysis. Under this model, the initiating
event in spontaneous lesion development in Plg2/2 miceprimary mechanism(s) responsible for spontaneous le-
sion formation and delayed wound healing in Plg2/2 would be chance or trauma-induced thrombosis and
extravascular fibrin deposition. Accumulation and per-mice. A substantial body of evidence favors a role of Plg
outside of fibrinolysis (e.g., general matrix degradation, sistence of thrombi and fibrin deposits within tissues in
the absence of Plg ultimately results in severe organprocollagenase and growth-factor activation), and a fail-
ure of Plg to act in nonfibrinolytic processes could initi- damage, impaired tissue repair, and life-threatening
illness.ate lesion formation and secondary local fibrin accumu-
lation. In this regard, it should be noted that the The fact that two Plg activators, uPA and tPA, appear
to be an evolutionarily stable feature among mammalsphenotypic rescue of Plg2/2 mice by the loss of Fib does
not formally exclude either the possibility that Plg partic- argues that these proteins play important, distinct bio-
logical roles. However, these unique roles are not neces-ipates in processes unrelated to fibrin(ogen) cleavage or
the possibility that Plg deficiency initiates spontaneous sarily outside of fibrinolysis. The studies presented here,
implying that the critical function of Plg is fibrinolysis,pathological events in vivo that are unrelated to fibrin(o-
gen). However, it is clear that any roles of Plg distinctly reinforce the concept that both physiolologically rele-
vant Plg activators serve in fibrinolysis. This view is alsouncoupled from fibrin(ogen) are either not essential for
development, growth to adulthood, efficient repair of supported by comparative studies of mice with single
and combined deficits in uPA, tPA, and uPAR (Carmelietskin wounds, and long-term survival, or these biological
roles are effectively compensated for by other factors et al., 1994a; Bugge et al., 1996). Our working hypothesis
for the evolutionary advantage of the two distinct Plgin the absence of Plg. Furthermore, if Plg deficiency
in fact initiates fibrin(ogen)-independent pathological activators is that: i) uPA provides a mechanism for effi-
cient cell-mediated fibrinolysis driven by cell-surfaceevents, then these pathologies are either extremely sub-
tle or quickly resolved without the aggravating contribu- binding (uPAR-dependent fibrinolysis) and/or local se-
cretion (receptor-independent fibrinolysis) (Bugge et al.,tion of an impaired process related to fibrin(ogen) (e.g.,
fibrinolysis). Of course, the simplest model that can ac- 1996), and ii) tPA provides a mechanism for efficient
cell-independent fibrinolysis via its unique fibrin-bindingcount for the overall good health, longevity, and timely
wound healing of Plg2/2/Fib2/2 mice compared to Plg2/2 capability (Collen and Lijnen, 1994). Transcriptional reg-
ulation of PA, PA inhibitor, and uPAR by cytokines andmice is that the crucial physiological role of Plg in vivo
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other factors (Danø et al., 1985; Saksela and Rifkin, 1988; Generation of fibrin(ogen)- and Plg-deficient mice
shows that dramatic swings in the hemostatic balanceVassalli, 1994) and the coupling of uPA-uPAR to cell
adhesion (Waltz and Chapman, 1994), signal transduc- in either direction are compatible with life. However,
without these factors, life is extremely perilous. On thetion (Dumler et al., 1993), and protease-clearance sys-
tems (Strickland et al., 1995) may modulate or focus one hand, fibrin(ogen)-deficient animals are at risk for
catastrophic spontaneous or trauma-induced hemor-cellular fibrinolytic potential in vivo.
A detailed understanding of impaired wound healing rhagic events, and the challenge of pregnancy is uni-
formly fatal (Suh et al., 1995). On the other hand, Plg-in Plg2/2 mice will provide valuable insights into the
pathophysiological roles of Plg. Impediments in several deficient mice are progressively ravaged by severe
thrombosis, cannot effectively resolve wounds, andprocesses might account for the observed impaired
wound healing in Plg2/2 mice, including: i) reduction in have a short life expectancy. Although the deleterious
consequences of Plg deficiency can be alleviated by thelocal growth-factor or matrix-protease activation, ii) fail-
ure to generate biologically active fibrin-degradation absence of fibrin(ogen), the extraordinary suspension of
the hemostatic balance genetically established in Plg2/2/products, iii) reduction in the ability of responding cells
to dissect proteolytically through the fibrin-rich provi- Fib2/2 mice is no less precarious than that in Fib2/2 mice;
like Fib2/2 mice, Plg2/2/Fib2/2 mice are at risk for life-sional matrices, or iv) some combination of disorders.
Althoughnodata ispresentlyavailable regardinggrowth- threatening bleeding and cannot support a pregnancy
beyond midgestation. Clearly, an opposing and bal-factor and zymogen activation within wound fields in
Plg2/2 mice, if either of these processes were restricted anced system of coagulation and fibrinolytic factors is
critical to preserve vascular integrity, to maintain freeto the point of slowing tissue repair in Plg2/2 mice, then
one would not anticipate that the loss of fibrin(ogen) blood flow in the vasculature, and to efficiently repair
tissue damage.would lift these restrictions or restore prompt wound
healing. A connection between production of fibrin-deg- If the only essential physiological role of Plg is fibrinol-
ysis, then this does not preclude other important rolesradation products and faulty wound healing in Plg2/2
mice is an intriguing alternative possibility in the light of of Plg in pathological settings. In the context of pharma-
cological challenges, microbial pathogens, metabolicthe substantial body of evidence suggesting that fibrin-
degradation products may influence inflammatory and disorders, and genetic abnormalities, plasmin might be
generated at sites or levels that promote proteolysisimmune responses (Plow and Edgington, 1986), cell pro-
liferation (Robson et al., 1993), angiogenesis (Thompson of a wider spectrum of substrates than cleaved under
normal physiological conditions. For example, produc-et al., 1993), chemotaxis (Skogen et al., 1988), and gene
expression (Robson et al., 1994). However, once again, tion of bacterial Plg activators such as streptokinase
and staphylokinase may provide a selective advantageif a major restriction on wound healing in Plg2/2 mice
resulted from loss of biologically active fibrin-degrada- to microorganisms in escaping fibrin-based immobiliza-
tion and penetrating host tissue barriers. Plg activationtion products, then one would not expect this obstacle
to be lifted if Fib and its derivatives were completely may also serve an important general proteolytic role in
tumor-cell invasion in vivo (Ossowski and Reich, 1983;eliminated from the system. Therefore, the proposal that
Plg deficiency results in a profound impediment in cellu- Danø et al., 1985, 1994; Mignatti et al., 1986; Ossowski,
1988; Ossowski et al.,1991a, 1991b; Crowley et al., 1993;lar infiltration into fibrin-rich matrices remains as the
simplest hypothesis consistent with phenotypic rescue Kook et al., 1994). Since fibrin appears to be a common
component of the tumor stroma (Dvorak, 1986), tumorobserved in Plg2/2/Fib2/2 mice.
The hypothesis that Plg facilitates cellular penetration cells may benefit from plasmin-mediated fibrinolysis in
the same sense that migrating keratinocytes appear toof fibrin-containing matrices also fits with earlier results
describing the unusual “blunted” morphology of kera- benefit when confronting fibrin-rich wound fields. How-
ever, tumor cells might also capitalize on the ability oftinocyte wedges migrating into thewound fields of Plg2/2
mice (Rømer et al., 1996). It should be noted that uPA plasmin to activate latent growth factors and proen-
zymes or degrade general matrix components (Danø etand uPAR expression are induced in migrating keratino-
cytes within skin wounds (Rømer et al., 1991, 1994). al., 1985, 1994; Saksela and Rifkin,1988). Any advantage
conferred on tumor cells by overexpression of PAs andTherefore, local conversion of Plg to plasmin and subse-
quent fibrin degradation is a likely scenario in normal subsequent local plasmin-mediated proteolysis would
presumably be selectively maintained in the context ofwound repair.Plasmin is probably one member of a team
of carefully regulated and specialized matrix-degrading tumor progression, regardless of whether the plasmin
substrates were physiologically relevant. Plg2/2, Fib2/2,enzymes, including serine-, metallo-, and other classes
of proteases, which together serve in matrix remodeling and Plg2/2/Fib2/2 mice provide a unique opportunity to
explore not only the role of Plg and fibrin(ogen) in tumorand cellular reorganization of wound fields. Plasmin may
be particularly useful in fibrin solubilization, and without progression and metastasis but also to examine the
interplay of these factors indisease. Similarly,we expectit, cellular reorganization of fibrin-rich matrices is se-
verely impeded. However, despite slow progress in that these animals will also be a major asset in examining
the role of Plg and fibrin(ogen) in atherosclerosis (Plumpwound repair, wounds in Plg2/2 mice eventually resolve
with an outcome that is generally comparable to that of et al., 1992), sickle-cell disease (Trudel et al., 1994),
fibrotic lung disease (Eitzman et al., 1996), bacterial in-control mice. Thus, an interesting unresolved question
is what protease(s) contributes to fibrin clearance in the fection (Gyetko et al., 1996), and other diseases that are
easily modeled in mice.absence of Plg?
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